Therefore, we performed an indirect comparison of KEYNOTE-181, ATTRACTION-3, and ESCORT studies to explore the optimal choice of anti-PD1 treatment for previously treated advanced ESCC. Here, PDCD1 is linked to esophageal squamous cell carcinoma.